Concepedia

Publication | Open Access

Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial.

DOIFull Paper Access

505

Citations

20

References

1994

Year

David D. Waters, Lyall Higginson, Peter Gladstone, B P Kimball, M. Le May, Stephen J. Boccuzzi, Jacques Lespérance
Circulation

Abstract

Lovastatin slows the progression of coronary atherosclerosis and inhibits the development of new coronary lesions.

References

YearCitations

Page 1